A novel neoadjuvant therapy combining PD-1 blockade and chemoradiotherapy shows promising results in treating advanced rectal ...

The method relies on a unique dental structure, past imaging, and existing dental records. It enables an initial ...

Rapid test enters trial to diagnose winter respiratory infections: United Kingdom Wednesday, January 28, 2026, 18:00 Hrs [IST] An NIHR-supported trial is investigating whether a 6 ...

Polyplastics Co., Ltd., a global leader in engineering thermoplastics, has developed two new DURAFIDE(R) polyphenylene sulfide (PPS) grades made of mechanically recycled content. The 40% glass ...

The new offering is part of Polyplastics' DURACIRCLE (R) initiative, which strives to achieve 100% circularity for engineering plastics. These new grades are offered through the company's ...

Polyplastics Co., Ltd., a global leader in engineering thermoplastics, has developed two new DURAFIDE(R) polyphenylene sulfide (PPS) grades made of mechanically ...

Doctors study for years to be able to 'dish out' medical advice. They're trained to know whether or not it's safe for a ...

The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.

Universal nirsevimab prophylaxis is linked to fewer respiratory syncytial virus cases and milder disease in infants, ...

Q4 2025 Earnings Call January 28, 2026 8:00 AM ESTCompany ParticipantsJohn Bedford - Vice President of Investor ...

With us today are Rainer Blair, our President and Chief Executive Officer, and Matt McGrew, our Executive Vice President and Chief Financial Officer. With that, I would like to turn the call over to ...